{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:15:42Z","timestamp":1787584542990,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijid.2021.05.047","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T23:35:01Z","timestamp":1621899301000},"page":"479-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Comparison of approaches for IgG avidity calculation and a new highly sensitive and specific method with broad dynamic range"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-5592","authenticated-orcid":false,"given":"Visa","family":"Nurmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-3816","authenticated-orcid":false,"given":"Lea","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-4251","authenticated-orcid":false,"given":"Maria F.","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8950-937X","authenticated-orcid":false,"given":"Lukas","family":"Weseslindtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1779-7960","authenticated-orcid":false,"given":"Klaus","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.0.CO;2-3","article-title":"Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection","volume":"56","author":"Aalto","year":"1998","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jmv.1890430308","article-title":"Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein-Barr virus serology","volume":"43","author":"Andersson","year":"1994","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.ijid.2021.05.047_bib0015","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1002\/jmv.26863","article-title":"The challenge of avidity determination in SARS-CoV-2 serology","volume":"93","author":"Bauer","year":"2021","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.ijid.2021.05.047_bib0020","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/infdis\/jiaa581","article-title":"SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors","volume":"222","author":"Benner","year":"2020","journal-title":"J Infect Dis"},{"issue":"1040","key":"10.1016\/j.ijid.2021.05.047_bib0025","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140016","article-title":"The average receiver operating characteristic curve in multireader multicase imaging studies","volume":"87","author":"Chen","year":"2014","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0030","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/JCM.01076-08","article-title":"Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for abbott architect cytomegalovirus and toxo IgG avidity assays","volume":"47","author":"Curdt","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ijid.2021.05.047_bib0035","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1128\/JCM.01663-15","article-title":"Significance of a positive toxoplasma immunoglobulin M test result in the United States","volume":"53","author":"Dhakal","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"9167","key":"10.1016\/j.ijid.2021.05.047_bib0040","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(98)08220-8","article-title":"Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling","volume":"353","author":"Dunn","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.047_bib0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jcv.2005.11.002","article-title":"Human parvovirus B19 infection during pregnancy\u2014value of modern molecular and serological diagnostics","volume":"35","author":"Enders","year":"2006","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.ijid.2021.05.047_bib0050","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22121","article-title":"Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies","volume":"31","author":"Fialov\u00e1","year":"2017","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0055","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1208\/aapsj0902029","article-title":"Appropriate calibration curve fitting in ligand binding assays","volume":"9","author":"Findlay","year":"2007","journal-title":"AAPS J"},{"issue":"10","key":"10.1016\/j.ijid.2021.05.047_bib0060","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2021.05.047_bib0065","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jim.2018.03.008","article-title":"An improved approach to estimate the avidity index of immunoglobulins: evaluation of the method using IgG anti-Toxoplasma gondii","volume":"457","author":"Garc\u00eda","year":"2018","journal-title":"J Immunol Methods"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.047_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jmv.1890270407","article-title":"Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing","volume":"27","author":"Hedman","year":"1989","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.047_bib0075","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/159.4.736","article-title":"Recent primary toxoplasma infection indicated by a low avidity of specific IgG","volume":"159","author":"Hedman","year":"1989","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00013542-199307000-00001","article-title":"Avidity of IgG in serodiagnosis of infectious diseases","volume":"4","author":"Hedman","year":"1993","journal-title":"Rev Med Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0085","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00917569","article-title":"Recent rubella virus infection indicated by a low avidity of specific IgG","volume":"8","author":"Hedman","year":"1988","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2021.05.047_bib0090","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jcv.2010.02.003","article-title":"Dating of human bocavirus infection with protein-denaturing IgG-avidity assays\u2014secondary immune activations are ubiquitous in immunocompetent adults","volume":"48","author":"Hedman","year":"2010","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/jcm.20.3.525-529.1984","article-title":"Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed","volume":"20","author":"Inouye","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.ijid.2021.05.047_bib0100","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/jcm.35.8.1972-1977.1997","article-title":"Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity","volume":"35","author":"Jenum","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"16","key":"10.1016\/j.ijid.2021.05.047_bib0105","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1097\/QAD.0000000000000429","article-title":"Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository","volume":"28","author":"Kassanjee","year":"2014","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.ijid.2021.05.047_bib0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2334-4-33","article-title":"A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid","volume":"4","author":"Kneitz","year":"2004","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2021.05.047_bib0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/CDLI.6.5.725-728.1999","article-title":"A new method with general diagnostic utility for the calculation of immunoglobulin G avidity","volume":"6","author":"Korhonen","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0120","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jcv.2007.10.015","article-title":"New advances in the diagnosis of congenital cytomegalovirus infection","volume":"41","author":"Lazzarotto","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ijid.2021.05.047_bib0125","article-title":"Kinetics of SARS-CoV-2 antibody avidity maturation and association with disease severity","author":"Luo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2021.05.047_bib0130","article-title":"Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity","author":"Lynch","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0135","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/JCM.02613-13","article-title":"Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study","volume":"52","author":"Maple","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ijid.2021.05.047_bib0140","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1128\/CVI.00406-12","article-title":"Measles virus IgG avidity assay for use in classification of measles vaccine failure in measles elimination settings","volume":"19","author":"Mercader","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.ijid.2021.05.047_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00320-18","article-title":"Development and use of an endpoint titration assay to characterize mumps IgG avidity following measles, mumps, and rubella vaccination and wild-type mumps infection","volume":"3","author":"Mercader","year":"2018","journal-title":"mSphere"},{"issue":"8302","key":"10.1016\/j.ijid.2021.05.047_bib0150","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","article-title":"Consequences of confirmed maternal rubella at successive stages of pregnancy","volume":"2","author":"Miller","year":"1982","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","article-title":"Immediate and long term outcome of human parvovirus B19 infection in pregnancy","volume":"105","author":"Miller","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.ijid.2021.05.047_bib0160","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00089-13","article-title":"Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns","volume":"20","author":"Murat","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0165","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/infdis\/jiw005","article-title":"Use of hepatitis C virus (HCV) immunoglobulin G antibody avidity as a biomarker to estimate the population-level incidence of HCV infection","volume":"214","author":"Patel","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jcla.20172","article-title":"Improved method to calculate the antibody avidity index","volume":"21","author":"Perciani","year":"2007","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"10.1016\/j.ijid.2021.05.047_bib0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jcv.2010.05.004","article-title":"Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays","volume":"48","author":"Revello","year":"2010","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.ijid.2021.05.047_bib0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/PL00011289","article-title":"Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii","volume":"20","author":"Roberts","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2021.05.047_bib0185","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/171.3.710","article-title":"Accurate serodiagnosis of B19 parvovirus infections by measurement of Igg avidity","volume":"171","author":"S\u00f6derlund","year":"1995","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2021.05.047_bib0190","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/infdis\/172.6.1431","article-title":"Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19","volume":"172","author":"S\u00f6derlund","year":"1995","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.ijid.2021.05.047_bib0195","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jviromet.2011.04.001","article-title":"Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis","volume":"174","author":"Wandinger","year":"2011","journal-title":"J Virol Methods"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9071(199802)54:2<145::AID-JMV13>3.0.CO;2-I","article-title":"The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis","volume":"54","author":"Weissbrich","year":"1998","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0205","first-page":"214","article-title":"The chemokine CXCL-10 is a marker of infection stage in individuals with DNAemia due to parvovirus B19","volume":"215","author":"Weseslindtner","year":"2017","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1128\/CVI.00356-12","article-title":"Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies","volume":"20","author":"Villard","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.ijid.2021.05.047_bib0215","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ijid.2021.05.047_bib0220","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","article-title":"Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases","volume":"119","author":"Zachou","year":"2006","journal-title":"Clin Immunol (Orlando, Fla)"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971221004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:06:01Z","timestamp":1761120361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971221004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"alternative-id":["S1201971221004495"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.047","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of approaches for IgG avidity calculation and a new highly sensitive and specific method with broad dynamic range","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2021.05.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}